Magnus Medical, Inc. is a pioneering medical device company that specializes in developing advanced neuromodulation technology aimed at addressing major depressive disorder (MDD). With a focus on innovative treatments for those suffering from treatment-resistant depression, Magnus Medical is at the forefront of mental health solutions, utilizing cutting-edge neuroscience to improve patient outcomes.
The SAINT system is an advanced neuromodulation device that employs transcranial magnetic stimulation (TMS) to deliver individualized and accelerated treatment for major depressive disorder. This innovative approach focuses on identifying precise brain targets, ensuring that treatment is tailored to the unique physiology of each patient.
SAINT effectively resolves the challenges faced by patients with treatment-resistant depression by providing a faster-acting alternative to traditional antidepressants, particularly for those who have experienced inadequate responses to existing medications.
Magnus Medical addresses the significant issue of treatment-resistant depression, offering hope to patients who feel hopeless due to the ineffectiveness of conventional therapies.